ArticleBlood2012

A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer.

Michelle Elvington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.